Skip to main content

Table 6 Median survival time by AFP level of 200 ng/ml at baseline and post initial TACE

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

AFP groups n Median Survival time, months (IQR) P value
AFP0 < 200 and AFP1 < 200 135 34.7 (19.9 - 56.1) 0.0001
AFP0 < 200 and AFP1 ≥ 200 5 19.4 (14.2 - 29.6)
AFP0 ≥ 200 and AFP1 < 200 12 19.9 (13.3 - 27.7)
AFP0 ≥ 200 and AFP1 ≥ 200 25 18.2 (9.2 - 26.1)